Status:
COMPLETED
Reducing HIV Risk Among Pregnant Women in Drug Treatment
Lead Sponsor:
Rhode Island Hospital
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
HIV Risk Behavior
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
We propose to develop and pilot test an intervention that addresses both sex- and drug-related HIV risk behavior among pregnant women in drug treatment. In the first phase of the study, we will conduc...
Detailed Description
HIV is a critical and costly health problem for American women. Among pregnant drug abusers, sex- and drug-related HIV risk behavior occur at alarming rates. While motivationally-enhanced HIV risk beh...
Eligibility Criteria
Inclusion
- 18 years of age or older, less than 32 weeks gestation, drug dependence (other than nicotine), have engaged in sex- or drug-related HIV risk behaviors at least monthly for 3 months prior to recruitment -
Exclusion
- Currently psychotic, unable to provide names and contact information for two people who could serve as locators
- \-
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2010
Estimated Enrollment :
98 Patients enrolled
Trial Details
Trial ID
NCT00332813
Start Date
February 1 2006
End Date
October 1 2010
Last Update
March 28 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rhode Island Hospital
Providence, Rhode Island, United States, 02903